Status Asthmaticus
26
1
1
10
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
15.4%
4 terminated out of 26 trials
71.4%
-15.1% vs benchmark
15%
4 trials in Phase 3/4
50%
5 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (26)
Treating Exacerbations of Asthma With Oral Montelukast in Children
The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
B2-Adrenergic Receptor Polymorphisms
High Flow Nasal Cannula in Children With Status Asthmaticus
Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus
NiPPV in the Treatment of Acute Asthma Exacerbations
BPAP in Pediatric Asthma Pilot Study
Pilot Simulation RCT of Telemedical Support for Paramedics
Comparison of Albuterol for Status Asthmaticus
Steroids in Children Hospitalized With Asthma
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations
HFCWO in Hospitalized Asthmatic Children
Pleth Variability and Asthma Severity in Children
A Prospective Trial of BiPAP Administration vs. Non-positive Pressure Therapy for Pediatric Status Asthmaticus
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
Evaluation Montelukast in the Treatment of Status Asthmaticus